Limit search to available items
Book Cover
E-book

Title The competitive status of the U.S. pharmaceutical industry : the influences of technology in determining international industrial competitive advantage / prepared by the Pharmaceutical Panel, Committee on Technology and International Economic and Trade Issues [and] Office of the Foreign Secretary, National Academy of Engineering [and] Commission on Engineering and Technical Systems, National Research Council ; Lacy Glenn Thomas, rapporteur
Published Washington, D.C. : National Academy Press, 1983

Copies

Description 1 online resource (xii, 102 pages) : illustrations, charts
Contents Overview of U.S. pharmaceutical industry -- Competitive position of the U.S. pharmaceutical industry -- Determinants of national pharmaceutical competitive advantage -- New developments affecting the industry -- Options for American industrial policy
Bibliography Includes bibliographical references and index
Notes Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL
digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL
Print version record
Subject Pharmaceutical industry -- United States
Pharmaceutical industry
Competition, International.
Drug Industry
BUSINESS & ECONOMICS -- Industries -- Pharmaceutical & Biotechnology.
Competition, International
Pharmaceutical industry
Tecnologia.
Ciencia E Tecnologia.
Industrias (Desenvolvimento)
Industria Farmaceutica (Economia)
Industrializacao (Economia)
United States
Form Electronic book
Author Thomas, Lacy Glenn.
National Academy of Engineering. Committee on Technology and International Economic and Trade Issues. Pharmaceutical Panel.
National Academy of Engineering. Office of the Foreign Secretary.
National Research Council (U.S.). Commission on Engineering and Technical Systems.
ISBN 0585217831
9780585217833
Other Titles Competitive status of the US pharmaceutical industry